Prof. Charalampos C. Moustakidis | Nuclear Physics | Research Excellence Award

Published on by Physicist Particle

Prof. Charalampos C. Moustakidis | Nuclear Physics | Research Excellence Award

Professor of Physics | Aristotle University of Thessaloniki | Greece

Prof. Charalampos C. Moustakidis is a globally recognized theoretical physicist whose scholarly contributions are centered on Nuclear Physics with sustained impact across fundamental and applied domains. His expertise in Nuclear Physics spans nuclear structure, dense nuclear matter, Nuclear Physics of neutron stars, Nuclear Physics driven equations of state, and Nuclear Physics based interpretations of astrophysical observables. Prof. Charalampos C. Moustakidis has authored more than fifty peer reviewed publications, widely cited within the international Nuclear Physics community, reflecting strong scientific influence and continuity. His research in Nuclear Physics integrates advanced theoretical modeling, computational Nuclear Physics, and interdisciplinary links between Nuclear Physics, astrophysics, and particle phenomena. He has established extensive international collaborations, strengthening the global Nuclear Physics research ecosystem and contributing to high level editorial, reviewing, and scientific leadership activities. The societal impact of his Nuclear Physics work is evident in advancing fundamental understanding of compact astrophysical objects, extreme matter, and universal physical laws, reinforcing the strategic value of Nuclear Physics in modern science and technology. Google Scholar profile of 2527 Citations, 28 h- index, 53 i10-index.

Citation Metrics (Google Scholar)

2527
1900
1250
600
0

Citations

2527

h-index

28

i10-index

53

Citations

h-index

i10-index

Featured Publications


The stability of relativistic stars and the role of the adiabatic index

General Relativity and Gravitation, 2017
 •Cited by 248


Information entropy, information distances, and complexity in atoms

The Journal of Chemical Physics, 2005
 •Cited by 226


Direct detection of dark matter rates for various WIMPs

Nuclear Physics B, 2007
 •Cited by 110


Proton-neutron pairing in the deformed BCS approach

Physical Review C, 2003
 •Cited by 107

Dr. Anca Melintescu | Nuclear Physics | Research Excellence Award

Published on by Physicist Particle

Dr. Anca Melintescu | Nuclear Physics | Research Excellence Award

Senior Scientist First Degree equivalent to Professor | Horia Hulubei National Institute of Physics and Nuclear Engineering | Romania

Dr. Anca Melintescu is an internationally recognized researcher whose work demonstrates sustained excellence in Nuclear Physics with a strong focus on Nuclear Physics applications to environmental systems, radiological impact assessment, and risk modeling. Her expertise in Nuclear Physics integrates advanced mathematical modeling, Nuclear Physics based transfer processes of radionuclides, and Nuclear Physics driven assessment frameworks used at global level. She has authored and coauthored more than forty peer reviewed scientific publications, with extensive citations reflecting the relevance of her Nuclear Physics contributions. Her research collaborations span major international institutions and agencies, where her Nuclear Physics knowledge supports harmonized methodologies, decision support tools, and scientific guidance. Through advisory roles and editorial activities, she has strengthened the global Nuclear Physics research ecosystem and ensured high scientific standards. Her work in Nuclear Physics has delivered measurable societal impact by improving environmental safety, public exposure assessment, and policy relevant decision making. Her sustained leadership and collaboration in Nuclear Physics continue to influence international best practices and scientific innovation. Scopus profile of 519 Citations, 44 Documents, 14 h-index.

Citation Metrics (Scopus)

519
400
300
200
100
0

Citations

519

Documents

44

h-index

14

Citations

Documents

h-index

Featured Publications

Assoc. Prof. Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary | Nuclear Physics | Research Excellence Award

Published on by Physicist Particle

Assoc. Prof. Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary | Nuclear Physics | Research Excellence Award

Associate professor | Egyptian Atomic Energy Authority | Egypt

Assoc. Prof. Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary is a distinguished researcher recognized for her impactful scientific contributions and advanced work in radiobiology, radiation biochemistry, radioprotection, and translational cancer research within the broader sphere of Nuclear Physics applications. Her research output reflects a strong foundation in experimental radiation science and therapeutic modulation, anchored in Nuclear Physics principles and developed through extensive laboratory, preclinical, and molecular investigations. She has established a significant academic footprint through peer-reviewed publications, collaborative research activities, and innovative projects that support safe and beneficial integration of Nuclear Physics in medicine, health, and radiation-based disease management. Her professional trajectory demonstrates leadership in the interface between biochemical systems and ionizing radiation mechanisms, bringing the precision of Nuclear Physics into cancer therapy, oxidative stress regulation, radiotracer development, radiosensitization, and tissue-protective strategies. Her multidisciplinary approach links biochemical pathways, immune regulation, molecular signaling, and toxicological markers with radiation exposure outcomes, reinforcing the translational value of Nuclear Physics in understanding cellular responses and advancing therapeutic interventions. Through research collaborations across biochemistry, molecular oncology, pharmacology, and imaging sciences, she has contributed to improved diagnostic and therapeutic solutions that benefit public health and global scientific progress. Her publications, experimental investigations, and continuous participation in scientific conferences reflect her commitment to expanding knowledge in Nuclear Physics, supporting the development of new radioprotectants, natural compounds, radiopharmaceuticals, and imaging tools. Her academic service includes research supervision, manuscript review for recognized journals, laboratory and project management, and active contribution to scientific communities working in radiation-linked biomedical innovation. Her work strengthens the strategic role of Nuclear Physics in clinical safety, cancer therapeutics, biological protection, and medical advancement, generating outcomes of scientific and societal importance. Her Google Scholar profile indicates 327 Citations, 12 h-index, 12 i10-index.

Profiles: Google Scholar | ORCID

Featured Publications

1. El Bakary, N. M., Alsharkawy, A. Z., Shouaib, Z. A., & Barakat, E. M. S. (2020). Role of bee venom and melittin on restraining angiogenesis and metastasis in γ-irradiated solid Ehrlich carcinoma-bearing mice. Integrative Cancer Therapies, 19, 1534735420944476.

2. Medhat, A. M., Azab, K. S., Said, M. M., El Fatih, N. M., & El Bakary, N. M. (2017). Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice. Tumor Biology, 39(10), 1010428317728480.

3. Hafez, E. N., Moawed, F. S. M., Abdel-Hamid, G. R., & Elbakary, N. M. (2020). Gamma radiation-attenuated Toxoplasma gondii provokes apoptosis in Ehrlich ascites carcinoma-bearing mice generating long-lasting immunity. Technology in Cancer Research & Treatment, 19, 1533033820926593.

4. Azab, K. S., Maarouf, R. E., Abdel-Rafei, M. K., El Bakary, N. M., & Thabet, N. M. (2022). Withania somnifera (Ashwagandha) root extract counteract acute and chronic impact of γ-radiation on liver and spleen of rats. Human & Experimental Toxicology, 41, 09603271221106344.

5. Elbakry, M. M. M., ElBakary, N. M., Hagag, S. A., & Hemida, E. H. A. (2023). Pomegranate peel extract sensitizes hepatocellular carcinoma cells to ionizing radiation, induces apoptosis and inhibits MAPK, JAK/STAT3, β-catenin/NOTCH, and SOCS3 signaling. Integrative Cancer Therapies, 22, 15347354221151021.